Tom Whitehead knows which medicine works to treat his Crohn’s disease. But when he switched insurers in 2025, he says was denied coverage for the expensive medication, Remicade, which he received in a monthly infusion. He was instead put on what’s called a biosimilar, which is essentially a slightly different version of the drug made from the same materials.
The biosimilar did not work well for him. His symptoms worsened, he had urgent and unpredictable bowel movements, and he got kidney stones twice, ending up in the hospital, he says. His doctor’s office appealed the coverage denial after his bad side effects, he says, but the company upheld it and he could not get the medication he wanted.
So he turned to AI.
Whitehead found Warris Bokhari, the founder of Claimable, an AI tool that helps people appeal insurance denials for medication and other treatments. Claimable drafted a letter for him and told him to send it to.…